Research use only · Multi-region fulfillment · Support-assisted ordering
VestaResearch Supply
Empacon 25mg Tablets | 100-Count | EMPAGLIFLOZIN
PharmaWeight Loss & Metabolic

Empacon 25mg Tablets | 100-Count | EMPAGLIFLOZIN

$160

In stock

For in vitro laboratory research only. Not for human or veterinary consumption.

India Warehouse EMPAGLIFLOZIN — 25mg per tablet, 100-count pack. Type 2 diabetes, heart failure (HFrEF and HFpEF), and chronic kidney disease. Major cardiovascular and renal protective benefits beyond glucose lowering. Key warning: Hold during illness, fasting, and surgery (DKA risk even with normal glucose). Avoid if eGFR under 20. Genital hygiene essential. Euglycemic DKA can occur with normal blood sugar.

SKU
VES-005508-EMPACON-25MG-100TAB
Format
N/A
Use
Laboratory research only
Ask on Telegram

What is Empacon 25mg (EMPAGLIFLOZIN)?

Type 2 diabetes, heart failure (HFrEF and HFpEF), and chronic kidney disease. Major cardiovascular and renal protective benefits beyond glucose lowering.

How it Works

Inhibits SGLT2 in renal proximal tubules — blocks glucose reabsorption causing glucosuria. Also reduces cardiac preload/afterload via osmotic diuresis and natriuresis.

Quick Specs

Form
Oral tablets — pre-dosed
Active Ingredient
EMPAGLIFLOZIN
Dose per Tablet
25MG
Pack Size
10×10 (100 tablets)
Storage
Room temperature (15–25°C), cool dry place
Shelf Life
2–3 years (properly stored)

Common Side Effects

Genital mycotic infections (thrush), UTIs, increased urination, DKA risk (rare), volume depletion, hypotension. Fournier’s gangrene (rare but serious).

Safety Warnings

Hold during illness, fasting, and surgery (DKA risk even with normal glucose). Avoid if eGFR under 20. Genital hygiene essential. Euglycemic DKA can occur with normal blood sugar. International shipping: 7–14 days

Research use only

This material is supplied strictly for in vitro laboratory research. It is not intended for human or veterinary consumption, diagnosis, treatment, or household use.